Stimuli-responsive ferroptosis for cancer therapy

N Kang, S Son, S Min, H Hong, C Kim, J An… - Chemical Society …, 2023 - pubs.rsc.org
Ferroptosis, an iron-dependent programmed cell death mechanism, is regulated by distinct
molecular pathways of lipid peroxidation caused by intracellular iron supplementation and …

[HTML][HTML] Targeting aberrant RAS/RAF/MEK/ERK signaling for cancer therapy

U Degirmenci, M Wang, J Hu - Cells, 2020 - mdpi.com
The RAS/RAF/MEK/ERK (MAPK) signaling cascade is essential for cell inter-and intra-
cellular communication, which regulates fundamental cell functions such as growth, survival …

[HTML][HTML] Oncogenic driver mutations in non-small cell lung cancer: Past, present and future

M Chevallier, M Borgeaud, A Addeo… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Lung cancer, of which non-small lung cancer is the most common subtype, represents the
leading cause of cancer related-death worldwide. It is now recognized that a significant …

Whole-genome landscapes of major melanoma subtypes

NK Hayward, JS Wilmott, N Waddell, PA Johansson… - Nature, 2017 - nature.com
Melanoma of the skin is a common cancer only in Europeans, whereas it arises in internal
body surfaces (mucosal sites) and on the hands and feet (acral sites) in people throughout …

Integrative clinical genomics of metastatic cancer

DR Robinson, YM Wu, RJ Lonigro, P Vats, E Cobain… - Nature, 2017 - nature.com
Metastasis is the primary cause of cancer-related deaths. Although The Cancer Genome
Atlas has sequenced primary tumour types obtained from surgical resections, much less …

Targeting alterations in the RAF–MEK pathway

R Yaeger, RB Corcoran - Cancer discovery, 2019 - AACR
The MAPK pathway is one of the most commonly mutated oncogenic pathways in cancer.
Although RAS mutations are the most frequent MAPK alterations, less frequent alterations in …

[HTML][HTML] Driver fusions and their implications in the development and treatment of human cancers

Q Gao, WW Liang, SM Foltz, G Mutharasu… - Cell reports, 2018 - cell.com
Gene fusions represent an important class of somatic alterations in cancer. We
systematically investigated fusions in 9,624 tumors across 33 cancer types using multiple …

[HTML][HTML] Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer

YM Wu, M Cieślik, RJ Lonigro, P Vats, MA Reimers… - Cell, 2018 - cell.com
Using integrative genomic analysis of 360 metastatic castration-resistant prostate cancer
(mCRPC) samples, we identified a novel subtype of prostate cancer typified by biallelic loss …

[HTML][HTML] The molecular taxonomy of primary prostate cancer

A Abeshouse, J Ahn, R Akbani, A Ally, S Amin… - Cell, 2015 - cell.com
There is substantial heterogeneity among primary prostate cancers, evident in the spectrum
of molecular abnormalities and its variable clinical course. As part of The Cancer Genome …

[HTML][HTML] Integrative clinical genomics of advanced prostate cancer

D Robinson, EM Van Allen, YM Wu, N Schultz… - Cell, 2015 - cell.com
Toward development of a precision medicine framework for metastatic, castration-resistant
prostate cancer (mCRPC), we established a multi-institutional clinical sequencing …